Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Abbisko Therapeutics, Akeso, Allgenesis Biotherapeutics, Alterity Therapeutics, Bioray Pharmaceutical, Gannex Pharma, Immutep, Immvira Group, Innovent Biologics, JCR Pharmaceuticals, Neurocrine Biosciences, Otsuka Pharmaceutical, Pharmabcine, Qilu Pharmaceutical, Recce Pharmaceuticals, Senhwa Biosciences, Takeda Pharmaceutical.